Amicus- This is their 2nd time. In August 2006, due to market conditions, the Company withdrew its IPO. At least for the AT2101 molecule (treatment for Gaucher disease), they will compete with PLX too.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.